THE ECONOMIC IMPACT OF ADDING CEFTAROLINE FOSAMIL TO HOSPITAL FORMULARY FOR COMMUNITY ACQUIRED BACTERIAL PNEUMONIA: A HOSPITAL BUDGET IMPACT ANALYSIS IN THE UNITED STATES

被引：0
|
作者：
Huang, X. Y. [1 ]
Lodise, T. [2 ]
Friedland, D. [3 ]
Beresford, E. J. [1 ]
机构：
[1] Forest Res Inst Inc, Jersey City, NJ USA
[2] Albany Coll Pharm & Hlth Sci, Albany, NY USA
[3] Cerexa Inc, Oakland, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A238 / A238
页数：1
相关论文
共 50 条
  • [1] THE ECONOMIC IMPACT OF ADDING CEFTAROLINE FOSAMIL TO A US HOSPITAL FORMULARY FOR ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS
    Huang, X. Y.
    Lodise, T.
    Friedland, D.
    Beresford, E. J.
    VALUE IN HEALTH, 2012, 15 (04) : A238 - A238
  • [2] Budget impact of adding doripenem to a hospital formulary
    Kongnakorn, T.
    Merchant, S.
    Akhras, K.
    Ingham, M.
    Mody, S.
    Mwamburi, M.
    Caro, J. J.
    VALUE IN HEALTH, 2008, 11 (03) : A94 - A94
  • [3] Economic analysis of ceftaroline fosamil for treating community-acquired pneumonia in Spain
    Torres, Antoni
    Bassetti, Matteo
    Welte, Tobias
    Rivolo, Simone
    Remak, Edit
    Peral, Carmen
    Charbonneau, Claudie
    Hammond, Jennifer
    Ansari, Wajeeha
    Grau, Santiago
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (02) : 148 - 155
  • [4] Ceftaroline fosamil use in hospitalized patients with acute bacterial skin and skin structure infections: Budget impact analysis from a hospital perspective
    Huang, Xingyue
    Beresford, Eric
    Lodise, Thomas
    Friedland, H. David
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (12) : 1057 - 1064
  • [5] Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
    Maggiore, Christy
    Vazquez, Jose A.
    Guervil, David J.
    Ramani, Ananthakrishnan
    Jandourek, Alena
    Cole, Phillip
    Friedland, H. David
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 557 - 563
  • [6] Capture: Ceftaroline Fosamil For The Treatment Of Community Acquired Bacterial Pneumonia (cabp): Year 1
    Udeani, G.
    Jandourek, A.
    Li, Y.
    Friedland, H. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection
    Casapao, Anthony M.
    Steed, Molly E.
    Levine, Donald P.
    Rybak, Michael J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (08) : 1177 - 1186
  • [8] Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis
    Campos, Catia Cilloniz
    Mendez, Raul
    Peroni, Hector
    Garcia-Vidal, Carolina
    Rico, Veronica
    Menendez, Rosario
    Torres, Antoni
    Soriano, Alex
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [9] Ceftaroline Fosamil For The Treatment Of Community-Acquired Bacterial Pneumonia In The Elderly: Capture Study Experience
    Udeani, G.
    Evans, J.
    Cole, P.
    Smith, A.
    Friedland, H. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [10] Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections
    Lodise, Thomas P.
    Low, Donald E.
    DRUGS, 2012, 72 (11) : 1473 - 1493
12345